- Exchange: Stockholm
- Sector: Technology
- Industry: Software
- Sub-Industry: Application Software
Snapshot for Aerocrine AB (AEROB)
| Open: | 9.7000 | Day's Range: | 9.5000 - 9.7500 | Volume: | 50,820 |
|---|---|---|---|---|---|
| Previous Close: | 9.6000 | 52wk Range: | 9.5000 - 15.5000 | 1-Yr Rtn: | -11.11% |
Key Statistics for AEROB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. OMX | - |
| Earnings Per Share (SEK) (ttm) | -1.5374 |
| Est. EPS (SEK) (12/2013) | -1.2750 |
| Est. PEG Ratio | - |
| Market Cap (M SEK) | 1,483.98 |
| Shares Outstanding (M) | 154.58 |
| 30 Day Average Volume | 250,140 |
| Price/Book (mrq) | 7.8861 |
| Price/Sale (ttm) | 9.4454 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AEROB
Company Profile & Key Executives for AEROB
Aerocrine AB researches, developes, and sells systems and products for measuring airway inflammation. The Company has developed a method for diagnosing inflammatory diseases, especially asthma, but also in the gastrointestinal tract and the urogenital organs. Aerocrine's software system is sold through distributors worldwide.
| Rolf A ClassonChairman | Scott MyersPresident/CEO |
| Michael ColerusChief Financial Officer | Kathleen Rickard "Kathy"Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AEROB News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page